跳至主要内容
临床试验/NCT04189172
NCT04189172进行中(未招募)不适用

Multicenter, International, Prospective, Observational, Study Using Neuro-Patch® in Duraplasty in Neurosurgery (MiDura)

Aesculap AG7 个研究点 分布在 2 个国家目标入组 328 人开始时间: 2020年2月6日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
Aesculap AG
入组人数
328
试验地点
7
主要终点
Incidence of complications

研究概览

简要总结

The aim of this study is to collect systematically and proactively data regarding the performance of Neuro-Patch, like complications and handling, under daily clinical practice when used as intended by the manufacturer

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Written informed consent
  • Age > 18 years
  • Duraplasty using Neuro-Patch® according to the Instructions for Use

排除标准

  • Use in infected regions
  • Use in open cerebrocranial traumata
  • Use in open spina bifida
  • Known hypersensitivity to implant materials
  • Pregnancy
  • Representation by a legal guardian or under involuntary commitment

研究组 & 干预措施

Neuro-Patch

Patients receiving Neuro-Patch® for duraplasty

结局指标

主要结局

Incidence of complications

时间窗: until follow-up (up to one year after surgery)

Incidence of complications, with (potential) causal relationship to Neuro-Patch

次要结局

  • Handling measures(Intraoperative)
  • Incidence of complications not related to Neuro Patch(until follow-up (up to one year after surgery))

研究者

发起方
Aesculap AG
申办方类型
Industry
责任方
Sponsor

研究点 (7)

Loading locations...

相似试验